Saliva and Extracellular Vesicles for Neurodegenerative Diseases
Recruiting
Observational Study
Neurodegenerative Diseases
Parkinson Disease
Alzheimer Disease
Parkinsonism
Mild Cognitive Impairment (MCI)
Prodromal Parkinson's Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 45 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 242 (estimated)
- Sponsor
- Fondazione Don Carlo Gnocchi ETS · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Early diagnosis of Neurodegenerative diseases (NDDs) and accurate patient profiling are key goals needed to tailor prompt personalized therapeutic strategies that can significantly impact disease progression and patients' quality of life. The project will validate a novel, cost-effective and quick biophotonic-based method for early and differential diagnosis of NDDs (Parkinson's disease, atypical …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* AD: standard criteria for dementia due to AD with AD neurochemical demonstration.
* PD: MDS Criteria; modified Hoehn\&Yahr stages; stable pharmacological treatment (last 4 weeks).
* AtP: current consensus diagnostic criteria for progressive supranuclear palsy; corticobasal deg…
Contacts